CuraSen Therapeutics Announces Strategic Investment from the Alzheimer's Drug Discovery Foundation to Advance CST-3056, an Alpha-1A Adrenoceptor Agonist, for the Treatment of Alzheimer's Disease

Press/Media

Period9 Oct 2023

Media coverage

1

Media coverage

  • TitleCuraSen Therapeutics Announces Strategic Investment from the Alzheimer's Drug Discovery Foundation to Advance CST-3056, an Alpha-1A Adrenoceptor Agonist, for the Treatment of Alzheimer's Disease
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date9/10/23
    PersonsHoward Fillit
View all 1
View less